Substance P enhances the inhibition of osteoblastic cell differentiation induced by lipopolysaccharide from Porphyromonas gingivalis

Journal of Periodontology

Volumn 75, Issue 7, 2004, Pages 974-981

  Azuma, Hideki ^a   Kido, Jun Ichi ^a   Ikedo, Dai ^a   Kataoka, Masatoshi ^a   Nagata, Toshihikko ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Bone metabolism; Cell differentiation; Gingival crevicular fluid; Lipopolysaccharides; Osteoblasts; Osteoclasts; Periodontal diseases; Porphyromonas gingivalis; Stress adverse effects

Indexed keywords

ALKALINE PHOSPHATASE; BACTERIUM LIPOPOLYSACCHARIDE; COLLAGEN TYPE 1; OSTEOCALCIN; OSTEOPONTIN; SIALOPROTEIN; SPANTIDE; SUBSTANCE P; SUBSTANCE P ANTAGONIST; SUBSTANCE P RECEPTOR; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BONE MATRIX; BONE METABOLISM; BONE STRESS; CALVARIA; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; FETUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PORPHYROMONAS GINGIVALIS; PROTEIN EXPRESSION; RAT;

ALKALINE PHOSPHATASE; ANALYSIS OF VARIANCE; ANIMALS; BONE MATRIX; BONE REGENERATION; CELL DIFFERENTIATION; CELLS, CULTURED; LIPOPOLYSACCHARIDES; OSTEOBLASTS; PERIODONTAL DISEASES; PORPHYROMONAS GINGIVALIS; RATS; RATS, WISTAR; RECEPTORS, NEUROKININ-1; SUBSTANCE P;

EID: 4444312989     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.7.974     Document Type: Article

References (43)

1. Otsuka M, Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol Rev 1993;73:229-308.
2. Harrison S, Geppetti P. Substance P. Int J Biochem Cell Biol 2001;33:555-576.
3. Laurenzi MA, Persson MA, Dalsgaard CJ, Ringden D. Stimulation of human B lymphocyte differentiation by the neuropeptide substance P and neurokinin A. Scand J Immunol 1989;30:695-701.
4. Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, Erspamer V. The tachykinin peptide family. Pharmacol Rev 2002;54:285-322.
5. Goto T, Yamaza T, Kido MA, Tanaka T. Light- and electron-microscopic study of the distribution of axons containing substance P and the localization of neurokinin-1 receptor in bone. Cell Tissue Res 1998;293:87-93.
6. Goto T, Kido MA, Yamaza T, Tanaka T. Substance P and substance P receptors in bone and gingival tissues. Med Electron Microsc 2001;34:77-85.
7. Mori T, Ogata T, Okumura H, Shibata T, Nakamura Y, Kataoka K. Substance P regulates the function of rabbit cultured osteoclast; Increase of intracellular free calcium concentration and enhancement of bone resorption. Biochem Biophys Res Commun 1999;262: 418-422.
8. Adamus MA, Dabrowski ZJ. Effect of the neuropeptide substance P on the rat bone marrow-derived osteogenic cells in vitro. J Cell Biochem 2001;81:499-506.
9. Hanioka T, Takaya K, Matsumori Y, Matsuse R, Shizukuishi S. Relationship of the substance P to indicators of host response in human gingival crevicular fluid. J Clin Periodontol 2000;27:262-266.
10. Linden GJ, McKinnell J, Shaw C, Lundy FT. Substance P and neurokinin A in gingival crevicular fluid in periodontal health and disease. J Clin Periodontol 1997;24: 799-803.
11. Iumatov EA, Poppai M, Ratsak R. Changes in the substance P content of the blood and hypothalamus during experimental emotional stress. Biull Eksp Biol Med 1985; 99:397-399.
12. Nieber K, Roske I, Oehme P. Stress-induced changes of the noradrenergic transmitter release in adrenals and the influence of substance P. Biomed Biochim Acta 1989;48: 557-559.
13. Breivik T, Thrane PS, Murison R, Gjermo P. Emotional stress effects on immunity, gingivitis and periodontitis. Eur J Oral Sci 1996; 104:327-334.
14. Genco RJ, Ho AW, Grossi SG, Dunford RG, Tedesco LA. Relationship of stress, distress, and inadequate coping behaviors to periodontal disease. J Periodontol 1999;70: 711-723.
15. Linden GJ, Mullally BH, Freeman R. Stress and the progression of periodontal disease. J Clin Periodontol 1996; 23:675-680.
16. Kadono H, Kido J, Kataoka M, Yamauchi N, Nagata T. Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalls. Infect Immun 1999;67:2841-2846.
17. Bellows C, Aubin JE, Heersche, JNM, Antosz ME. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 1986;38:143-154.
18. Kumada H, Haishima Y, Umemoto T, Tanamoto K. Structural study on the free lipid A isolated from lipopolysaccharide of Porphyromonas gingivalis. J Bacteriol 1995; 177:2098-2106.
19. Ikedo D, Ohishi K, Yamauchi N, Kataoka M, Kido J, Nagata T. Stimulatory effects of phenytoin on osteoblastic differentiation of fetal rat calvaria cells in culture. Bone 1999;25:653-660.
20. Lowry OH, Roberts NR, Wu ML, Hixon WS, Crawford EJ. The quantitative histochemistry of brain. II. Enzyme measurements. J Biol Chem 1954;207:19-37.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
22. Goode T, O'Connell J, Sternini C, et al. Substance P (neurokinin-1) receptor is a marker of human mucosal but not peripheral mononuclear cells: Molecular quantitation and localization. J Immunol 1998;161:2232-2240.
23. Tsuchida K, Shigemoto R, Yokota Y, Nakanishi S. Tissue distribution and quantitation of the mRNAs for three rat tachykinin receptors. Eur J Biochem 1990;193:751-757.
24. Togari A, Arai M, Mizutani S, Mizutani S, Koshihara Y, Nagatsu T. Expression of mRNAs for neuropeptide receptors and β-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells. Neurosci Lett 1997; 233:125-128.
25. Germonpre PR, Bullock GR, Lambrecht BN, et al. Presence of substance P and neurokinin 1 receptors in human sputum macrophages and U-937 cells. Eur Respir J 1999;14:776-782.
26. Marriott I, Bost KL. IL-4 and IFN-7 up-regulate substance P receptor expression in murine peritoneal macrophages. J Immunol 2000;165:182-191.
27. Rusanen M, Korkala O, Gronblad M, Partanen S, Nederstrom A. Evolution of substance P immunofluorescent nerves in callus tissue during fracture healing. J Trauma 1987;27:1340-1343.
28. Lundy FT, Mullally BH, Burden DJ, Lamey P-J, Shaw C, Linden GJ. Changes in substance P and neurokinin A in gingival crevicular fluid in response to periodontal treatment. J Clin Periodontol 2000;27:526-530.
29. Owen TA, Aronow M, Shalhoub V, et al. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990;143:420-430.
30. Yao K, Todescan R Jr., Sodek J. Temporal changes in matrix protein synthesis and mRNA expression during mineralized tissue formation by adult rat bone marrow cells in culture. J Bone Miner Res 1994;9:231-240.
31. Komori T, Yagi H,. Nomura S, et al. Targeted disruption of Cbfa 1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89: 755-764.
32. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001;13:85-94.
33. Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988;241:1218-1221.
34. Rameshwar P, Gascón P. Substance P (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma: Potential autoregulatory role for these cytokines in SP receptor expression and induction. Blood 1995;86:482-490.
35. Kuo H-P, Lin H-C, Hwang K-H, Wang C-H, Lu L-C. Lipopolysaccharide enhances substance P-mediated neutrophil adherence to epithelial cells and cytokine release. Am J Respir Crit Care Med 2000;162:1891-1897.
36. Luber-Narod J, Kage R, Leeman SE. Substance P enhances the secretion of tumor necrosis factor-α from neuroglial cells stimulated with lipopolysaccharide. J Immunol 1994;152:819-824.
37. Taichman RS, Hauschka PV. Effects of interleukin-1β and tumor necrosis factor-α on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitro. Inflammation 1992; 16:587-601.
38. Gilbert L, He X, Farmer P, et al. Inhibition of osteoblast differentiation by tumor necrosis factor-α. Endocrinology 2000;141:3956-3964.
39. Stashenko P, Dewhirst F, Rooney ML, Desjardins LA, Heeley JD. Interleukin-1β is a potent inhibitor of bone formation in vitro. J Bone Miner Res 1987;2:559-565.
40. Genco RJ, Ho AW, Kopman J, Grossi SQ, Dunford RG, Tedesco LA. Models to evaluate the role of stress in periodontal disease. Ann Periodontol 1998;3:288-302.
41. Lian JB, Shalhoub V, Aslam F, et al. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: Dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression. Endocrinology 1997;138:2117-2127.
42. Canalis E, Delany AM. Mechanisms of glucocorticoid action in bone. Ann N Y Acad Sci 2002;966:73-81.
43. Shapira L, Houri-Haddad Y, Frolov I, Halabi A, Ben-Nathan D. The effect of stress on the inflammatory response to Porphyromonas gingiualis in a mouse subcutaneous chamber model. J Periodontol 1999;70:289-293.